Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Cincinnati Children's Hospital Medical Center · Royal Sussex County Hospital · +10 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
878
total citations
- FWCI
- 52.31
- Percentile
- 100%
- References
- 32
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Tuberous sclerosis
- Everolimus
- Lymphangioleiomyomatosis
- Angiomyolipoma
- Medicine
- Placebo
- Clinical endpoint
- Internal medicine
No related works found for this paper.